Arjo AB (publ)
ARJO-B.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.4B
Close$
$46.56
68.1% upside
Current Fair Value
68.1% upsideUndervalued by 68.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.40 Billion |
|---|---|
| Enterprise Value | $12.13 Billion |
| Dividend Yield | $0.95 (3.50%) |
| Earnings per Share | $1.23 |
| Beta | 0.69 |
| Outstanding Shares | 272,369,573 |
Return
| Return on Equity | 4.96% |
|---|---|
| Return on Assets | 2.45% |
| Return on Invested Capital | 6.13% |
Valuation & Multiples
| P/E Ratio | 19.14 |
|---|---|
| PEG | 54.78 |
| Price to Sales | 0.71 |
| Price to Book Ratio | 0.99 |
| Enterprise Value to Revenue | 1.12 |
| Enterprise Value to EBIT | 15.25 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.72 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 14, 2026
EPS Estimate
$0.41
Average shareholder expectationRevenue Estimate
$2.72 B
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
$0.39
Average shareholder expectationRevenue Estimate
$2.76 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Arjo AB (publ)
7,000 employees
CEO: Andreas Elgaard Arjo AB (publ) is a global leader in providing medical devices and innovative solutions tailored for patients experiencing limited mobility and age-related health conditions. Operating across North America, Western Europe, and other inte...